2.1. Reagents
Dextrin from potato starch (Dx, Fluka, Saint Louis, MO, USA), divinyl sulfone (DVS, 99.5%, TCI, Zwijndrecht, Belgium), ibuprofen[(RS)-2-(4-Isobutylphenyl)propanoic acid] (IBU, 98%, BDLpharm, Kaiserslautern, Germany), erythromycin [(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione] (ERY, >98%, TCI, Zwijndrecht, Belgium), atenolol [(RS)-2-[4-[2-hydroxy-3-(1-methylethylamino)propoxy]phenyl]ethanamide](98%, TCI, Zwijndrecht, Belgium), hydrochlorothiazide [6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide] (> 97%, TCI, Zwijndrecht, Belgium) ciprofloxacin [1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid] (CIP, 98%, TCI, Zwijndrecht, Belgium), ofloxacin [(RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic acid] (98%, BDLpharm, Kaiserslautern, Germany), carbamazepine [5H-Dibenzo[b,f]azepine-5-carboxamide] (98%, BDLpharm, Kaiserslautern, Germany), were used as received. Anhydrous sodium carbonate (99.5%) and anhydrous sodium acetate (99%) were purchased from Sigma-Aldrich.
2.4. Sorption Studies
Sorption experiments were conducted at room temperature in batch mode. For the study of the sorption of IBU, 0.1 g of polymer and 10 mL of IBU water solutions (concentration ranging from 0.5 to 2 mg/L) were mixed in Falcon tubes and shaken in a tube rotator (VWR) for 3 h. Then the IBU solution was separated by centrifugation at 4000 rpm and its concentration was quantified with an F2000 fluorescence spectrophotometer (Hitachi) by interpolating the emission at 290 nm (λex 260 nm) in a calibration curve [
17].
For the evaluation of the polymer as sorbents of a cocktail of drugs, 0.1 g of polymer and 10 mL of a water solutions containing a mixture of carbamazepine, atenolol, hydrochlorothiazide, ofloxacin, CIP and ERY ranging for 2 to 50 µg/L of each drug was assayed as described above and analyzed by mass spectrometry. With the help of an Acquity FTN AutoSampler (Waters Corporation), a volume of 10 µL of sample was injected in an ultrapultraperformance liquid chromatograpy (UPLC) system consisting of a Quaternary Solvent Manager Acquity (Waters Corporation) equipped with a column C18 BEH 1.7 mm 100 mm and coupled with a triple quadrupole mass spectrometer XEVO-TQS (Waters Corporation). The mobile phase of the UPLC system consisted of 0.1% (v/v) formic acid in water (Solvent A) and 0.1% (v/v) formic acid v/v in acetonitrile (Solvent B). The flow rate was 0.3 mL/min and the gradient was from 80% solvent A: 20% solvent B to 80% solvent A: 20% solvent B within 8 min and then back to 80% solvent A: 20% solvent B within 2 min. Electrospray ionization mass spectra (ESI-MS) were acquired in the positive (ESI +) except for hydrochlorothiazide, that was acquired in the negative (ESI -). LC-MS/MS acquisition parameters for the target molecules were as follows: Carbamazepine237.00 > 178.99 and 237.00 > 194.07; Atenolol 267.13 > 145.01 and 267.13 > 190.05; CIP 332.23 > 288.16 and 332.23 > 314.10; Ofloxacin 362.24 > 261.11 and 362.24 > 318.17; ERY 734.81 > 158.10 and 734.81 > 576.35; Hydrochlorothiazide 295.93 > 205.00 and 295.93 > 268.96.
The performance of the polymers as sorbents was evaluated by the sorption coefficient, Kd, which is defined as the ratio between the concentration of drug in solution (Ce) and in the polymer (qe) and is estimated as the slope of the plot qe (mg/kg) versus Ce (mg/L) at equilibrium.